Found: 8 articles

Article Edition
I.S. Gulian, E.P. Bystritskaya, N.Yu. Otstavnykh, E.V. Khudchenko, E.V. Eliseeva, V.I. Apanasevich, M.P. Isaeva
GSTT1 and GSTM1 deletion polymorphism as a predictor of response to hormonal therapy for breast cancer
№11 / 2023
M.M. Konstantinova (1), L.I. Kuzina (2)
Will our clinical practice change with the availability of new diagnostic methods, drug therapy and assessment of its effectiveness? Clinical case: hormone receptor-positive, HER2-negative metastatic breast cancer
№11 / 2021
S.A. Protsenko, G.M. Teletaeva, E.A. Degtiareva, E.V. Levchenko, N.E. Levchenko, A.V. Mishchenko, I.A. Burovik, A.S. Artemyeva, E.N. Imyanitov, A.I. Semenova, A.V. Novik, D.Kh. Latipova
PEComas: what are the treatment options? literature review and personal experience
№7 / 2019
O.A. Shidlovskaya, E.D. Belousova
HORMONE THERAPY OF SYNDROMES WITH PROLONGED SPIKE-WAVE ACTIVITY DURING SLEEP
№s4-16 / 2016
V.A. Tchernyaev
HORMONE THERAPY OF PROSTATE CANCER
№8 / 2013
V.F.Semiglazov 1, V. V. Semiglazov 2
Adjuvant Hormonal Therapy In Perimenopausal Women With Er-positive Breast Cancer
№18 / 2012
I.N. Gogotadze, P.N. Krotin
Puberty uterine bleeding: the experience of management in day patient department
№6 / 2011
Semiglazov V.F., Semiglazov V.V., Dashyan G.A., Paltuev R.M., Migmanova N.Sh., Shedrin D.E., Grechuhina I.A., Bessonov A.A., Penkov K.D., Merabishvili V.M.
Male breast cancer
№6 / 2010


Бионика Медиа